乐心医疗
(300562)
| 流通市值：20.72亿 | | | 总市值：27.12亿 |
| 流通股本：1.67亿 | | | 总股本：2.19亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 283,737,915.92 | 986,210,596.57 | 757,129,146.52 | 521,364,786.34 |
| 营业总成本 | 250,558,737.99 | 886,886,005.21 | 685,490,345.42 | 470,355,356.57 |
| 其他经营收益 | | | | |
| 营业利润 | 32,845,584.39 | 86,326,857.9 | 68,426,189.91 | 44,078,881.45 |
| 利润总额 | 32,823,158.86 | 84,345,735.61 | 67,754,775.06 | 44,125,388.82 |
| 净利润 | 31,892,054.37 | 80,268,782.1 | 64,762,159.33 | 41,251,286.28 |
| 每股收益 | | | | |
| 其他综合收益 | -6,631.94 | -12,668,222.99 | -723,961.64 | -812,328.02 |
| 综合收益总额 | 31,885,422.43 | 67,600,559.11 | 64,038,197.69 | 40,438,958.26 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 995,985,063.59 | 976,392,818.16 | 975,113,884.72 | 1,031,208,772.87 |
| 非流动资产: | | | | |
| 非流动资产合计 | 411,556,051.41 | 414,994,769.56 | 444,614,711.99 | 451,373,358.07 |
| 资产总计 | 1,407,541,115 | 1,391,387,587.72 | 1,419,728,596.71 | 1,482,582,130.94 |
| 流动负债: | | | | |
| 流动负债合计 | 351,991,978.08 | 372,877,872.97 | 410,572,565.66 | 477,439,297.06 |
| 非流动负债: | | | | |
| 非流动负债合计 | 14,981,749.02 | 15,478,032.59 | 16,741,131.35 | 16,344,876.16 |
| 负债合计 | 366,973,727.1 | 388,355,905.56 | 427,313,697.01 | 493,784,173.22 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,062,138,458.66 | 1,024,420,998.98 | 1,012,993,130.97 | 1,009,496,104.28 |
| 股东权益合计 | 1,040,567,387.9 | 1,003,031,682.16 | 992,414,899.7 | 988,797,957.72 |
| 负债和股东权益合计 | 1,407,541,115 | 1,391,387,587.72 | 1,419,728,596.71 | 1,482,582,130.94 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 289,784,876.28 | 1,093,958,043.38 | 805,286,355.49 | 523,536,942.38 |
| 经营活动现金流出小计 | 255,221,422.48 | 941,090,404.86 | 700,924,431.54 | 475,283,077.91 |
| 经营活动产生的现金流量净额 | 34,563,453.8 | 152,867,638.52 | 104,361,923.95 | 48,253,864.47 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 853,501.33 | 1,659,346,432.98 | 1,016,737,826.07 | 934,883,850.16 |
| 投资活动现金流出小计 | 548,280,606.69 | 1,666,592,972.48 | 1,231,554,717.48 | 941,324,395.28 |
| 投资活动产生的现金流量净额 | -547,427,105.36 | -7,246,539.5 | -214,816,891.41 | -6,440,545.12 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 7,187,549.66 | 56,214,265.64 | 48,747,900 | - |
| 筹资活动现金流出小计 | 191,558.62 | 259,717,544.87 | 203,749,711.39 | 74,328,926.11 |
| 筹资活动产生的现金流量净额 | 6,995,991.04 | -203,503,279.23 | -155,001,811.39 | -74,328,926.11 |
| 汇率变动对现金及现金等价物的影响 | -1,452,387.72 | -431,289.67 | -2,193,023.48 | 572,284.04 |
| 现金及现金等价物净增加额 | -507,320,048.24 | -58,313,469.88 | -267,649,802.33 | -31,943,322.72 |
| 期末现金及现金等价物余额 | 160,414,097.24 | 667,734,145.48 | 458,397,813.03 | 694,104,292.64 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -58,313,469.88 | - | -31,943,322.72 |